GWAS |
- Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) ( 24025145)
- Craniofacial microsomia ( 26853712)
- Lupus nephritis in systemic lupus erythematosus ( 24925725)
- Post bronchodilator FEV1/FVC ratio ( 26634245)
- Skin pigmentation ( 28300201)
|
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Bipolar disorder ( 31043756)
- Coronary artery calcified atherosclerotic plaque score in type 2 diabetes ( 29221444)
- Pursuit maintenance gain ( 29064472)
- Sulfasalazine-induced agranulocytosis ( 28762467)
|